| 1831 |
ANUCARE OINTMENT |
ZINC OXIDE 107.5 MG/G, PERU BALSAM 18.8 MG/G, BENZYL BENZOATE 12.5 MG/G |
OINTMENT |
TUBE |
FOR THE RELIEF OF ITCHING, BURNING AND SORENESS OF HAEMORRHOIDS AND MINOR RECTAL INFLAMMATIONS AND IRRITATIONS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 5108/21 |
07-FEB-2024 |
06-FEB-2027 |
View |
| 1832 |
APD FCON 150 |
FLUCONAZOLE USP 150 MG |
TABLET |
PVC - BLISTER |
CRYPTOCOCCAL MENINGITIS, COCCIDIOIDOMYCOSIS, INVASIVE CANDIDIASIS, MUCOSAL CANDIDIASIS INCLUDING OROPHARYNGEAL, OESOPHAGEAL CANDIDIASIS, CANDIDURIA AND CHRONIC MUCOCUTANEOUS CANDIDIASIS, CHRONIC ORAL ATROPHIC CANDIDIASIS, VAGINAL CANDIDIASIS, DERMATOMYCOSIS. |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
05 I 5488/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 1833 |
APD PROMET 25 |
PROMETHAZINE HYDROCHLORIDE USP 25 MG |
TABLET |
PVC-BLISTER |
AS SYMPTOMATIC TREATMENT FOR ALLERGIC CONDITIONS OF THE UPPER RESPIRATORY TRACT AND SKIN INCLUDING ALLERGIC RHINITIS, URTICARIA AND ANAPHYLACTIC REACTIONS DUE TO DRUGS AND FOREIGN PROTEINS, AS AN ANTIEMETIC. |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
05 I 5489/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 1834 |
APD VOFEN GEL |
DICLOFENAC DIETHYLAMINE BP 1.16 % W/W EQ.TO DICLOFENAC SODIUM 1 %W/W |
GEL |
TUBE |
RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, RHEUMATIC DAMAGE OF TISSUE, ACUTE PODAGRIC, PSORIATIC AND POST-TRAUMATIC ARTHRITIS, DEGENERATIVE DISEASES OF JOINTS, OSTEOCHONDRITIS OF SPINAL COLUMN, MYALGIA, NEURALGIA, TRAUMA PAIN |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICAL AND DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
02 I 5050/21 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 1835 |
ARBITAN 150 MG TABLET |
IRBESARTAN USP 150 MG |
TABLET |
ALU-PVDC BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION |
NULL |
MEMESCO CO.,LTD |
OPSONIN PHARMA LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
08 I 4532/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
| 1836 |
ASUMALIFE |
KETOTIFEN FUMARATE 1.38 MG EQ TO KETOTIFEN 1 MG/ 5ML |
SYRUP |
BOTTLE |
PROPHYLACTIC TREATMENT OF BRONCHIAL ASTHMA AND SYMPTOMATIC TREATMENT OF ALLERGIC RHINITIS, DERMATITIS, URTICARIA AND PRURITUS. IT IS NOT EFFECTIVE IN ABORTING ESTABLISHED ATTACKS OF ASTHMA |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
01 I 3421/10 |
07-JUN-2023 |
06-JUN-2026 |
View |
| 1837 |
AZICENT SUSPENSION 200 MG/5 ML |
AZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN ANHYDROUS 200 MG/5 ML |
SUSPENSION |
BOTTLE |
BRONCHITIS, COMMUNITY-ACQUIRED PNEUMONIA, SINUSITIS, PHARYNGITIS/TONSILITIS, OTITIS MEDIA, SKIN ANS SOFT TISSUE INFECTION, UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEA |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
05 I 5490/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 1838 |
AZICENT-500 |
AZITHROMYCIN DIHYDRATE USP EQ,TO AZITHROMYCIN ANHYDROUS 500 MG |
TABLET |
PVC/ALU BLISTER |
ACUTE BACTERIAL SINUSITIS, ACUTE OTITIS MEDIA, PHARYNGITIS, TONSILITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, MILD TO MODERATELY SEVERE COMMUNITY ACQUIRED PNEUMONIA, SKIN AND SOFT TISSUE INFECTIONS |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICAL AND DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
02 I 5051/21 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 1839 |
BIOTASE |
BIODIASTASE #1000 30MG, LIPASE AP6 5MG, NEWLASE 10MG |
CHEWABLE TABLET |
ALU-PVDC BLISTER |
AS AN ANJUVANT IN THE TREATMENT OF INDIGESTON AS WELL AS DIGESTIVE DISORDER MANIFESTED BY BLOATING, BELCHING, FLATULENCE, ABDOMINAL DISCOMFORT OR FEELING OF FULLNESS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 3317/09 |
28-APR-2023 |
27-APR-2026 |
View |
| 1840 |
BISLAN |
BROMHEXINE HCL 8MG |
TABLET |
ALU-PVC BLISTER |
A MUCOLYTIC AGENT USED IN THE TREATMENT OF RESPIRATORY DISORDERS ASSOCIATED WITH VISCID OR EXCESSIVE MUCUS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
03 I 2765/06 |
28-APR-2023 |
27-APR-2026 |
View |
